Lonza Group AG
LONN.SW
Get informed when a big investor buys or sells
+ FollowMarket Cap$49.11B
Close$
$-156.29
127.2% downside
Current Fair Value
127.2% downsideOvervalued by 127.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $49.11 Billion |
|---|---|
| Enterprise Value | $52.94 Billion |
| Dividend Yield | $5.00 (0.87%) |
| Earnings per Share | $-3.93 |
| Beta | 0.84 |
| Outstanding Shares | 69,844,229 |
Return
| Return on Equity | 7.67% |
|---|---|
| Return on Assets | 3.41% |
| Return on Invested Capital | 18.75% |
Valuation & Multiples
| P/E Ratio | -371.56 |
|---|---|
| PEG | -959.3 |
| Price to Sales | 3.12 |
| Price to Book Ratio | 4.95 |
| Enterprise Value to Revenue | 4.11 |
| Enterprise Value to EBIT | 20.05 |
| Enterprise Value to Net Income | 84 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.53 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 22, 2026
EPS Estimate
$8.70
Average shareholder expectationRevenue Estimate
$3.42 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Lonza Group AG
16,866 employees
CEO: Wolfgang Wienand Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and int...